As cell culture supplements, human platelet lysate (PL) and human platelet lysate serum (PLS) are alternatives to fetal bovine serum (FBS) due to FBS-related issues such as ethical concerns, variability between batches, and the possible introduction of xenogenic contaminants. This study compared the composition and efficacy of PL, PLS, and FBS as supplements in the culture and cryopreservation of human dermal fibroblasts, Wharton’s jelly-derived mesenchymal stem cells (WJ-MCS), and adipose tissue (AdMSC). Biochemical components, some growth factors, and cytokines present in each of them were analyzed; in addition, the cells were cultured in media supplemented with 5% PL, 5% PLS, and 10% FBS and exposed to different freezing and thawing solutions with the supplements under study. Biochemical parameters were found to be similar in PL and PLS compared to FBS, with some differences in fibrinogen and calcium concentration. Growth factors and cytokines were higher in PL and PLS compared to FBS. Cell proliferation and morphology showed no significant differences between the three culture media. Regarding the cryopreservation and thawing of cells, better results were obtained with PLS and FBS. In conclusion, PL and PLS are an excellent choice to replace the standard supplement of animal origin (FBS) in the media used for the culture and cryopreservation of fibroblasts, WJ-MSC, and AdMSC.
18 September 2017 in International Journal of Polymer Science
We investigated wound dressing composites comprising fibrils of bacterial cellulose (BC) grown by fermentation in the presence of polyvinyl alcohol (PVA) followed by physical crosslinking. The reference biointerface, neat BC, favoured adhesion of fibroblasts owing to size exclusion effects. Furthermore, it resisted migration across the biomaterial. Such effects were minimized in the case of PVA/BC membranes. Therefore, the latter are suggested in cases where cell adhesion is to be avoided, for instance, in the design of interactive wound dressings with facile exudate control. The bioactivity and other properties of the membranes were related to their morphology and structure and considered those of collagen fibres. Bioactive materials were produced by simple 3D templating of BC during growth and proposed for burn and skin ulcer treatment.
Los materiales poliméricos han tenido una imagen desfavorable, ya que son asociados con contaminación. Sin embargo, estos son de gran importancia para la biomedicina. Los polímeros son materiales muy versátiles, se pueden obtener de múltiples configuraciones químicas y mezclas para generar materiales compuestos con propiedades sinérgicas. En esta investigación se realizó un análisis científico y tecnológico de las aplicaciones biomédicas de biomateriales poliméricos y se recopila algunas de sus aplicaciones, propiedades mecánicas y características importantes para la industria biomédica. Los biomateriales poliméricos son una temática de punta como se refleja en el número de artículos científicios y de patentes. En la actualidad, estos biomateriales pueden llegar a reemplazar, reforzar o cumplir una función específica en el cuerpo humano. No obstante, debido a la complejidad de los sistemas biológicos aún se siguen presentando reacciones inmunes, que evitan el desarrollo de tejidos u órganos funcionales a escala de laboratorio.
1 December 2023 in Tissue Engineering Part B: Reviews
Mesenchymal stem cells (MSC) have been seen for years as great candidates for treating different diseases and an alternative to embryonic stem cells due to their differentiation capacity in vitro. More recent research has focused on their ability to modulate the immune response and regeneration at sites associated with inflammation, activities attributable to the release of trophic factors into the extracellular medium, a set of components known as the secretome. It has been possible to demonstrate the presence of these cells within the tumor microenvironment, which is associated with their tropism for sites of inflammation; however, their role here needs to be clarified. In different investigations, the feasibility of using MSC or their secretome to treat cancer has been sought, with these results being ambiguous. It has been described that MSC can be activated and present various phenotypes, which could explain the divergence in their action; however, these activation mechanisms and the different phenotypes still need to be well-known. This review explores MSC and their use in regenerative medicine with a targeted approach to cancer.
21 March 2014 in Journal of Biomedical Materials Research Part A